In this preview of the 2014 San Antonio Breast Cancer Symposium, we take a look at some of the studies to watch for at this year's event.
Carlos L. Arteaga, MD
Advertisement
Articles by Carlos L. Arteaga, MD
Advertisement
Latest Updated Articles
Studies to Watch at SABCS 2014Published: December 8th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
3
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
4
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
5
